Rhabdomyoblastic differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy

被引：0
|
作者：
Liegl, B.
Hornick, J. L.
Antonescu, C. R.
Corless, C. L.
Letcher, C. D. M.
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
50
引用
收藏
页码：14A / 14A
页数：1
相关论文
共 50 条
  • [41] Dual differentiation in gastrointestinal stromal tumors
    GonzalezCampora, R
    Vazquez, AH
    Davidson, HG
    ULTRASTRUCTURAL PATHOLOGY, 1997, 21 (03) : 311 - 313
  • [42] Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland
    Tryggvason, Geir
    Hilmarsdottir, Bylgja
    Gunnarsson, Gudmundur H.
    Jonsson, Jon Johannes
    Jonasson, Jon G.
    Magnusson, Magnus K.
    APMIS, 2010, 118 (09) : 648 - 656
  • [43] Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase
    Sommer, G
    Agosti, V
    Ehlers, I
    Rossi, F
    Corbacioglu, S
    Farkas, J
    Moore, M
    Manova, K
    Antonescu, CR
    Besmer, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6706 - 6711
  • [44] Management of complicated tumor response to tyrosine-kinase inhibitors in gastrointestinal stromal tumors
    Tirotta, Fabio
    Fumagalli, Elena
    Colombo, Chiara
    Morosi, Carlo
    Barisella, Marta
    Radaelli, Stefano
    Frezza, Anna M.
    Casali, Paolo G.
    Gronchi, Alessandro
    Fiore, Marco
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 256 - 261
  • [45] Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
    Mrinal M. Gounder
    Robert G. Maki
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 25 - 43
  • [46] Understanding Rechallenge and Resistance in the Tyrosine Kinase Inhibitor Era Imatinib in Gastrointestinal Stromal Tumor
    Agulnik, Mark
    Giel, Jennifer L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 417 - 422
  • [47] Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
    Gounder, Mrinal M.
    Maki, Robert G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 : 25 - 43
  • [48] Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib
    Vij, Mukul
    Patra, Susama
    Rela, Mohamed
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (03) : 291 - 293
  • [49] Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy
    Qiu, Hai-Bo
    Zhou, Zhong-Guo
    Feng, Xing-Yu
    Liu, Xue-Chao
    Guo, Jing
    Ma, Ming-Zhe
    Chen, Ying-Bo
    Sun, Xiao-Wei
    Zhou, Zhi-Wei
    MEDICINE, 2018, 97 (02)
  • [50] DIFFERENTIATION AND RISK ASSESSMENT OF GASTROINTESTINAL STROMAL TUMORS
    FRANQUEMONT, DW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 103 (01) : 41 - 47
12345